Health

  • April 22, 2026

    5th Circ. Bars Dead Veteran's VA Surgery Suit As Untimely

    The estate of a dead veteran who filed a medical malpractice lawsuit 18 years after an unauthorized operation at a Veterans Affairs hospital didn't bring the suit within Mississippi's seven-year deadline for medical malpractice claims, the Fifth Circuit ruled Wednesday.

  • April 22, 2026

    Judge Lets Pharma Co. Seal Parts Of Ex-GC's Retaliation Suit

    A Texas state judge on Wednesday granted Houston-based Empower Clinic Services LLC's bid to permanently and partially seal a petition by its former general counsel that alleges a smear campaign by the company after he confronted them about conduct he said was unlawful.

  • April 22, 2026

    Sorrento, M3 Get Pause On RICO Suit Naming Jackson Walker

    A Texas bankruptcy judge on Wednesday agreed to put on hold a lawsuit in California federal court alleging Jackson Walker LLP and executives at Sorrento Therapeutics and M3 Partners conspired to forum shop in Texas so the drug developer could seek Chapter 11 protection there.

  • April 22, 2026

    Simpson Thacher Adds Another Kirkland Finance Alum In Calif.

    Simpson Thacher & Bartlett LLP has hired another former Kirkland & Ellis LLP partner to join its recently formed capital structure solutions practice in the San Francisco area, where she'll focus on banking and other finance matters, Simpson Thacher announced Wednesday.

  • April 22, 2026

    Commure Took Health Co.'s Software Trade Secrets, Suit Says

    A San Diego-based healthcare technology services company has accused Commure Inc. of stealing trade secrets to launch competing cloud-based software, framing the alleged conduct as an instance of a large company "backed by big money" breaking the rules to obtain a much smaller competitor's information.

  • April 22, 2026

    Ex-Conn. Prosecutor Fights Drug Co. Bid To Appeal DQ Denial

    Insurers Humana Inc. and Molina Healthcare Inc. urged a federal judge to turn down a group of generic-drug makers' request for an immediate trip to the Third Circuit, arguing the drugmakers' bid for a second chance to disqualify Connecticut's former assistant attorney general from an antitrust case was not qualified for an interlocutory appeal.

  • April 22, 2026

    Kirkland Keeps Growing In Philly With Private Equity Atty

    Kirkland & Ellis LLP announced Wednesday it is continuing to expand its new Philadelphia office with the recent addition of a private equity attorney, who has moved his practice after more than 12 years with Morgan Lewis & Bockius LLP.

  • April 22, 2026

    4 Firms Build Amneal's Up To $1.1B Kashiv Biosimilars Buy

    Biopharmaceutical company Amneal Pharmaceuticals Inc. on Wednesday unveiled plans to acquire biosimilars-focused Kashiv BioSciences LLC in a deal worth up to $1.1 billion that was built by four law firms.

  • April 22, 2026

    Life Policy With $21M Payout Voided As Illegal Life Wager

    A Delaware federal court voided a life insurance policy as an unlawful wager on a now-deceased Florida woman's life, finding that Ameritas Life Insurance Corp. is entitled to retain the policy's $10 million death benefit and $11 million in premium payments.

  • April 22, 2026

    Healthcare REIT Raises $462M In IPO Advised By 4 Firms

    Healthcare-focused real estate investment trust National Healthcare Properties began trading Wednesday after raising $462 million in an initial public offering guided by Paul Weiss, Greenberg Traurig LLP, Sidley Austin LLP and Venable LLP.

  • April 21, 2026

    Nourish Can't Ax Wiretap Claims In Google Data Sharing Row

    An Illinois federal judge has refused to cut wiretap and negligence claims from a proposed class action accusing telehealth provider Nourish Inc. of deploying tracking tools that illegally transmitted website visitors' sensitive health information to Google, while tossing several privacy and contract allegations and rebuking the plaintiffs for filing a "press release complaint."

  • April 21, 2026

    Georgia Panel Tosses $123K Fee Award After Defense Win

    A Georgia appellate panel tossed on Tuesday an award of $123,000 in attorney fees to defense counsel after their win in a medical malpractice trial, ruling that a state judge failed to show how she arrived at the figure.

  • April 21, 2026

    Congress Rallies More For Bills On Copyrights Than Patents

    There have been more intellectual property bills floated in Congress that are supportive of copyright rights than patent rights, according to a new report looking at how lawmakers treat the IP system.

  • April 21, 2026

    Amgen Faces ERISA Suit Over Health Plan Tobacco Surcharge

    A former Amgen Inc. employee filed a proposed class action in California federal court Tuesday alleging the biotech company discriminatorily imposes an "egregiously high" $150-a-month surcharge on employees who use tobacco products, while failing to adequately notify them of reasonable pathways to avoid the fees, in violation of federal benefits law.

  • April 21, 2026

    ProMedica Wins Bid To Unseal Gov't Probe Briefs In FCA Suit

    Nursing home operator ProMedica Health Systems Inc. has succeeded in its bid to unseal government briefs in a whistleblower case over alleged problems caused by understaffing at its facilities, with a Pennsylvania federal judge ruling that a presumption of openness with court records trumped the government's concerns about disclosure of its investigative methods.

  • April 21, 2026

    Watchdog Says Ex-Fla. Rep Used Straw Donors For Campaign

    A Washington, D.C.-based watchdog organization accused former Florida Rep. Sheila Cherfilus-McCormick of improperly funding her 2022 reelection bid to the U.S. House of Representatives, saying she orchestrated a complex straw donor scheme to funnel $725,000 in Haitian "dark money" into her campaign. 

  • April 21, 2026

    Defendant Says Rx Software Was Guide For Docs, Not Fraud

    A man accused of swindling Medicare out of nearly half a billion dollars was simply trying to make it easier for doctors to navigate labyrinthine Medicare regulations to get orthotic braces approved for their patients, his attorney told jurors in Florida federal court Tuesday.

  • April 21, 2026

    Woman Pleads Guilty In $51M Medicare Fraud Scheme

    A San Diego woman has pled guilty in California federal court to billing Medicare for nearly $51 million in fake prescriptions and trying to hide the scheme through money laundering and kickbacks to doctors.

  • April 21, 2026

    Feds Say Pot Foes Lack Standing To Stop CMS Hemp Program

    Federal health regulators have told a D.C. federal judge that anti-pot advocates' attempt to block a program to ease access for Medicare beneficiaries to federally legal hemp products that have small amounts of THC was not bolstered by the addition of a pharmaceutical company as a co-plaintiff.

  • April 21, 2026

    Fed. Circ. Keeps Banner Witcoff And Saiber Off Patent Case

    The Federal Circuit kept intact the disqualification of two law firms from a patent ownership fight on Tuesday, saying it had not been shown a district judge made a clear error in removing them.

  • April 21, 2026

    2nd Circ. Chilly To Additional Discovery In Cigna Pension Suit

    The Second Circuit on Tuesday seemed reluctant to restart proceedings in a long-running suit against Cigna from retirees who challenged changes to their pensions, appearing unwilling to upend a decision to turn down post-judgment discovery in the class action.

  • April 21, 2026

    Squires Stands By Ending Skincare IPR Over ITC Overlap

    U.S. Patent and Trademark Office Director John Squires has shot down Sinclair Pharma Ltd.'s request to revive its challenge to Hydrafacial LLC's skin treatment patent, which the director had terminated based on related proceedings at the U.S. International Trade Commission.

  • April 21, 2026

    Medical Practice Faces Bid For Extra $22M After $49M Verdict

    The Westchester Medical Group PC should be forced to pay a Connecticut cancer patient and her husband an extra $22 million in interest, plus other costs, on top of a $49 million jury verdict for failing to diagnose the fatal illness in its early stages, the patient and husband have argued.

  • April 21, 2026

    Novo Nordisk Unit Can't Slip Former Exec's Sex, Age Bias Suit

    A Novo Nordisk unit must face a former finance director's lawsuit claiming she was fired because she was an older woman who complained about a male co-worker's behavior, with a North Carolina federal judge ruling her allegations were detailed enough to stay in court.

  • April 21, 2026

    Purdue Pharma Sentencing Punted For In-Person Attendance

    A New Jersey federal judge delayed Oxycontin maker Purdue Pharma's criminal sentencing by a week, saying rescheduling would give an in-person attendance option to hundreds of observers who tuned in virtually Tuesday.

Expert Analysis

  • Fresenius Ruling May Shift Anti-Kickback Enforcement

    Author Photo

    The Ninth Circuit's recent decision in Fresenius v. Bonta suggests that businesses have a First Amendment right to donate to certain charities, even if those donations are motivated by economic self-interest, potentially calling into question years of Anti-Kickback Statute proceedings against pharmaceutical manufacturers for making similar donations, says Jonah Knobler at Patterson Belknap.

  • Written Consent Ruling May Signal Change For Telemarketing

    Author Photo

    The Fifth Circuit's ruling in Bradford v. Sovereign Pest Control is a takedown of the Federal Communications Commission's prior express written consent regulation, and because Loper Bright empowers courts to disregard agency interpretations, Telephone Consumer Protection Act litigants now have an opportunity to challenge previously settled FCC regulations, orders and interpretations, say attorneys at Manatt.

  • Series

    Law School's Missed Lessons: How To Draft Pleadings

    Author Photo

    Most law school graduates step into their first jobs without ever having drafted a complaint, answer, motion or other type of pleading, but that gap can be closed by understanding the strategy embedded in every filing, writing with clarity and purpose, and seeking feedback at every step, says Eric Yakaitis at Haug Barron.

  • E-Discovery Quarterly: Recent Rulings On ESI Control

    Author Photo

    Several recent federal court decisions have perpetuated a split over what constitutes “control” of electronically stored information — with judges divided on whether the standard should turn on a party's legal right or practical ability to obtain the information, say attorneys at Sidley.

  • The Challenge Of Stabilizing Rural Hospitals On The Brink

    Author Photo

    The outlook for rural hospitals has grown more concerning, as recent policy and regulatory developments are decreasing hospital revenues and increasing the cost of uncompensated care, which may result in additional hospital closures, service reductions, or mergers and acquisitions, say Omur Celmanbet, Kristy Piccinini and Sabiha Quddus at FTI Consulting.

  • Insurer Lessons From 1st Wave Of GenAI Coverage Rulings

    Author Photo

    Several pending cases target the issue of whether generative AI may appropriately replace human professional decision-making, and though each case is still in discovery, the decisions thus far provide insurers with guidance on how courts may view these claims, say attorneys at Simpson Thacher.

  • The Role Of Operational Data In Tech Platform Liability Suits

    Author Photo

    As litigation becomes a de facto substitute for the regulation of major technology platforms, with plaintiffs advancing claims under product liability, public nuisance and consumer protection laws, among others, courts are evaluating how platform systems operate in practice based on large-scale operational data, say attorneys at Brattle.

  • 2 Discovery Rulings Break With Heppner On AI Privilege Issue

    Author Photo

    While a New York federal court’s recent ruling in U.S. v. Heppner suggests that some litigants’ communications with AI tools are discoverable, two other recent federal court decisions demonstrate that such interactions generally qualify for work-product protection under the Federal Rules of Civil Procedure, says Joshua Dunn at Brown Rudnick.

  • Bid Protest Spotlight: Evidence, Tailored Talks, Materiality

    Author Photo

    In this month's bid protest roundup, Brian Doll at MoFo delves into three recent decisions from the Government Accountability Office about the evidentiary standards necessary to sustain a protest, discussions tailored to individual proposals, and misrepresentation claims involving factors irrelevant to the agency's decision.

  • Series

    Isshin-Ryu Karate Makes Me A Better Lawyer

    Author Photo

    My involvement in martial arts, specifically Isshin-ryu, which has principles rooted in the eight codes of karate, has been one of the most foundational in the development of my personality, and particularly my approach to challenges — including in my practice of law, says Kaitlyn Stone at Barnes & Thornburg.

  • Class Actions At The Circuit Courts: April Lessons

    Author Photo

    In this month's review of class action appeals, Mitchell Engel at Shook Hardy identifies practice tips from three recent rulings involving allegations of racial discrimination in mortgage applications, health insurance networks and actual cash value losses.

  • Fraud Enforcement, Sentencing Face Unusual Convergence

    Author Photo

    The Trump administration’s newly created task force to eliminate fraud and the U.S. Sentencing Commission’s recent proposals to scale back certain elements of the federal sentencing framework seem to point in opposite directions, creating a collision of policy priorities that may reshape how fraud cases are charged, negotiated and sentenced for years to come, says David Tarras at Tarras Defense.

  • Peptide Policy Is Shifting Toward Sanctioned Compounding

    Author Photo

    The policy landscape for peptides is undergoing a significant shift under the Trump administration, moving toward a complex system of verified compounding and complementary enforcement that will likely bring peptides firmly back into the sphere of legitimate consumer products, say attorneys at Sheppard.

  • Keys To Building Defensible Psychedelic Therapy Programs

    Author Photo

    Given the rapidly evolving legal environment for psychedelic therapies and heightened liability and compliance risks facing providers, meticulous documentation, robust risk management protocols, and proactive engagement with professional organizations and insurers are essential strategies, say Kimberly Chew at Husch Blackwell and L. Alison McInnes at Mindful Health Solutions.

  • Opinion

    State Bars Need To Get Specific About AI Confidentiality

    Author Photo

    Lawyers need to put actual client information into artificial intelligence tools to get their full value, but they cannot confidently do so until state bars offer clear, formal authority on which plan tiers of the three most popular generative AI tools are safe to use when sharing specific client details, says attorney Nick Berk.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here